Dr. Scott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
Rm M-987
San Francisco, CA 94143Phone+1 415-476-1528Fax+1 415-502-1976
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2010 - 2012- University of California (San Francisco)Residency, Internal Medicine, 2006 - 2010
Yale School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2025- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Personalized HIV and STI Testing Tool Start of enrollment: 2019 Sep 18
- HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing Start of enrollment: 2017 Jan 09
Publications & Presentations
PubMed
- 306 citationsCabotegravir for HIV Prevention in Cisgender Men and Transgender WomenRaphael J. Landovitz, Deborah Donnell, Meredith E. Clement, Brett Hanscom, Leslie Cottle
The New England Journal of Medicine. 2021-08-11 - 21 citationsHIV self-testing and STI self-collection via mobile apps: experiences from two pilot randomized controlled trials of young men who have sex with menKatie B. Biello, Casey Horvitz, Shelby Mullin, Kenneth H. Mayer, Hyman M. Scott
Mhealth. 2021-04-20 - 7 citationsPopulation Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage Among San Francisco Men Who Have Sex With Men.Adrien Le Guillou, Susan Buchbinder, Hyman M. Scott, Albert Liu, Diane V. Havlir
Journal of Acquired Immune Deficiency Syndromes. 2021-12-01
Press Mentions
CROI 2023: Dr. Dieffenbach Shares Research Highlights on Long-Acting HIV Prevention and Treatment, COVID, and a Cure UpdateFebruary 22nd, 2023- ‘Here We Go Again’: Amid HIV/AIDS Connection, Fear of Racial Disparities for MPX GrowsSeptember 6th, 2022
- Test of a New 'Germline-Targeting' HIV Vaccine Prepares to LaunchMay 19th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
